Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial

scientific article published in October 2007

Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S1092852900015443
P698PubMed publication ID17934380

P50authorLuis Augusto RohdeQ45420577
P2093author name stringCristian Patrick Zeni
Silza Tramontina
Carla Ketzer de Souza
Gabriel Ferreira Pheula
P2860cites workPractice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar DisorderQ22242775
A rating scale for mania: reliability, validity and sensitivityQ29619299
Juvenile bipolar disorder in Brazil: clinical and treatment findings.Q35146068
Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.Q35868432
Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacologyQ35963737
The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart reviewQ36015766
Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review.Q36026701
Aripiprazole in children and adolescents: clinical experienceQ36256185
Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trialsQ36827082
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptorsQ44028935
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.Q45206307
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trialQ46681464
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age childrenQ46765699
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.Q47208132
ADHD in Brazil: the DSM-IV criteria in a culturally different populationQ47429768
Risk of Substance Use Disorders in Adolescents With Bipolar DisorderQ57400365
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHDQ73256558
P433issue10
P921main subjectbipolar disorderQ131755
attentionQ6501338
attention deficit hyperactivity disorderQ181923
P304page(s)758-762
P577publication date2007-10-01
P1433published inC N S SpectrumsQ15750260
P1476titleAripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial
P478volume12

Reverse relations

cites work (P2860)
Q37653402A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.
Q28073540Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis
Q57612470Aripiprazole in Bipolar Disorder
Q45990613Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.
Q45484599Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
Q34199313Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula
Q46637334Diminished 5-HT functioning in CBCL pediatric bipolar disorder-profiled ADHD patients versus normal ADHD: susceptibility to rapid tryptophan depletion influences reaction time performance
Q37299210Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
Q34611306Focus on aripiprazole: a review of its use in child and adolescent psychiatry
Q37557589Issues in the management of patients with complex attention-deficit hyperactivity disorder symptoms
Q37498921Obesity, serious mental illness and antipsychotic drugs.
Q46185243Pharmacotherapy in bipolar disorders during childhood and adolescence
Q27027052Pharmacotherapy of bipolar disorder in children and adolescents: an update
Q37742068Pharmacotherapy of bipolar disorder in children and adolescents: recent progress
Q37768441Psychopharmacology of pediatric bipolar disorder.
Q51054683Successful treatment of bipolar disorder II and ADHD with a micronutrient formula: a case study.

Search more.